ArticleCell death & disease2020

Novel HDAC inhibitor Chidamide synergizes with Rituximab to inhibit diffuse large B-cell lymphoma tumour growth by upregulating CD20.

Xu-Wen Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.